Last updated on May 2020

A Study of Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis


Brief description of study

The reason for this study is to see if the study drug baricitinib given orally is safe and effective in participants with JIA from 2 years to less than 18 years old.

Clinical Study Identifier: NCT03773978

Find a site near you

Start Over